<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title>海洋之心 - 心血管预防</title>
    <link>https://heart.lihaiyang.com</link>
    <description>心血管文献检索平台 - 最新收录论文</description>
    <language>zh-CN</language>
    <atom:link href="https://heart.lihaiyang.com/rss.php?category=%E5%BF%83%E8%A1%80%E7%AE%A1%E9%A2%84%E9%98%B2" rel="self" type="application/rss+xml"/>
        <item>
        <title>Anti-Ro/SSA-antibody testing for isolated atrioventricular block in adults: a diagnostic and therapeutic work-up.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=185</link>
        <description>暂无摘要</description>
        <pubDate>Fri, 20 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1093/eurheartj/ehag177</guid>    </item>
        <item>
        <title>Real-time acoustic monitoring of perinatal volume fluctuations in a pregnant woman after complex congenital heart disease surgery: a case report.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=186</link>
        <description>暂无摘要</description>
        <pubDate>Fri, 20 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1093/eurheartj/ehag208</guid>    </item>
        <item>
        <title>African Representation in Randomized Controlled Trials Published in Leading Medical and Cardiovascular Journals, 2019-2024.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=190</link>
        <description>Despite accounting for a substantial proportion of the global population and disease burden, African countries are underrepresented in randomized controlled trials (RCTs), including those informing cardiovascular (CV) care. In this study, we sought to quantify African representation in RCTs publishe</description>
        <pubDate>Fri, 20 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1016/j.jacc.2026.02.5097</guid>    </item>
        <item>
        <title>Genetic counselling implementation in dilated cardiomyopathy.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=193</link>
        <description>Genetic testing has become an integral part of the diagnostic workup of patients with dilated cardiomyopathy (DCM). While the initial goal of genetic testing was to identify family members at risk, recent advances have now extended their relevance to clinical decision-making. Our knowledge of the ge</description>
        <pubDate>Fri, 20 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1093/eurheartj/ehag159</guid>    </item>
        <item>
        <title>Development and Validation of the AI-HeartAge Model in Framingham and UK Biobank</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=179</link>
        <description>动脉压力波形形状传达了左心室和主动脉之间相互作用的信息，可提供生物学心脏年龄和心血管疾病风险的估计。人工智能心脏年龄（AI-HA）通过平均两个卷积神经网络的预测结果来估计，这些网络使用未校准的动脉张力测量或光电容积脉搏波波形作为输入，预测二尖瓣环组织多普勒e'和s'峰值速度。模型使用Framingham心脏研究参与者压力波形和超声心动图测量数据开发（N=6916名参与者，38174个波形，56%女性，平均年龄61±12岁）。在FHS基线桡动脉波形保留集（N=7018，54%女性，年龄50±16岁）和UK Biobank参与者（N=67986，53%女性，年龄57±8岁）中验证了AI-HA。在F</description>
        <pubDate>Thu, 19 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1161/HYPERTENSIONAHA.125.26209</guid>    </item>
        <item>
        <title>Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=175</link>
        <description>Patients with a transient ischemic attack (TIA) or minor stroke have an increased risk of subsequent stroke that persists for at least 10 years. We aimed to identify prognostic factors associated with long-term risk of stroke in this patient group, and estimate their population attribution fraction </description>
        <pubDate>Wed, 18 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1161/CIRCULATIONAHA.125.078763</guid>    </item>
        <item>
        <title>High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=173</link>
        <description>Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemi</description>
        <pubDate>Tue, 17 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1056/NEJMoa2516087</guid>    </item>
        <item>
        <title>Early atheroma prevention: a cost-effective approach to healthy cardiovascular ageing.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=172</link>
        <description>暂无摘要</description>
        <pubDate>Mon, 16 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1016/S0140-6736(26)00419-8</guid>    </item>
        <item>
        <title>Decentralized clinical trials in cardiovascular disease : A primer for clinical trialists.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=168</link>
        <description>Decentralized clinical trials (DCTs) move trial activities-such as recruitment, consent, delivery of the intervention, data collection and assessment of outcomes-away from traditional research sites to the homes or communities of patients. This participant-centered approach is accomplished through t</description>
        <pubDate>Sun, 01 Mar 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1016/j.ahj.2023.02.009</guid>    </item>
        <item>
        <title>Environmental risk factors and cardiovascular health.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=9</link>
        <description>Environmental risk factors-air pollution, noise, heat, chemical contamination, and light pollution-are increasingly recognized as key contributors to cardiovascular disease but remain underrepresented in clinical guidelines and public health strategies. This comprehensive review, developed under the</description>
        <pubDate>Thu, 01 Jan 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1093/eurheartj/ehag270</guid>    </item>
        <item>
        <title>From Air Pollution Association to Actionable Prevention: Silent Myocardial Fibrosis as the Next Frontier in Cardiovascular Imaging.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=82</link>
        <description></description>
        <pubDate>Thu, 01 Jan 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1093/ehjci/jeag105</guid>    </item>
        <item>
        <title>Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus.</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=125</link>
        <description>Glucagon-like peptide 1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2Is) have established cardiovascular benefits for patients with type 2 diabetes mellitus (T2DM), with similar class-level effectiveness found in previous studies. However, real-world comparative e</description>
        <pubDate>Thu, 01 Jan 2026 00:00:00 +0800</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.1016/j.jacc.2026.02.5123</guid>    </item>
        <item>
        <title>The burden of disease in Italy, 1990-2023: a subnational analysis from the Global Burden of Disease Study 2023</title>
        <link>https://heart.lihaiyang.com/?p=detail&amp;id=163</link>
        <description>本研究旨在全面评估1990至2023年意大利各地区的预期寿命、健康调整预期寿命、残疾生命年、早逝生命年和伤残调整生命年，识别时间、地理和性别特异性模式，为有针对性的公共卫生策略提供信息。研究使用全球疾病负担研究（GBD）2023年的估计数据，覆盖按性别、五大宏观地区和21个次国家位置分层的意大利人群。结果显示，1990年至2023年间，各地区和两性的预期寿命均大幅提高，尽管COVID-19大流行导致了暂时性下降。2023年男性年龄标准化伤残调整生命年的首要原因是缺血性心脏病，女性为阿尔茨海默病。焦虑障碍是女性年龄标准化伤残调整生命年的首要原因，自1990年以来显著增加。在男性中，缺血性心脏病仍</description>
        <pubDate>Mon, 30 Nov -001 00:00:00 +0805</pubDate>
        <category>心血管预防</category>
        <guid>https://doi.org/10.19191/EP26.1.A991.020</guid>    </item>
    </channel>
</rss>
